| Application no. and date | 09788621.2 (espacenet) (Federated) (European Patent Register), 20091209 | | Patent/reg. no. and date | DK/EP 2376499, 20150225 | | Publication date | 20111019 | | Priority no. and date | US 121668 P, 20081211 | | EP pub. no. and date |
EP 2376499 20111019 | | Effective date | | | Applicant/owner | CTI BIOPHARMA CORP., 3101 Western Avenue, Suite 600
Seattle, WA 98121, US | | Applicant ref. no. | P55901DK01 | | Inventor | LEE, Cheng Hsia Angeline, Block 764
Jurong West St 74
10-25
Singapore 640764, SG,
WILLIAM, Anthony Deodaunia, 32 Woodlands Cresent
02-07
Northoaks
Singapore 738087, SG,
DYMOCK, Brian, 20 Leonie Hill
16-20 Leonie Towers
Singapore 239222, SG | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 35/00 (2006.01) , C07D 498/04 (2006.01) | | Title | 11-(2-PYRROLIDIN-1-YL-ETHOXY)-14,19-DIOXA-5,7,26-TRIAZA-TETRACYCLO[19,3,1,1(2,6)1(8,12)]HEPTACOSA-1(25),2(26),3,5,8,10,12(27),16,21,23-DECAENCITRATSALT | | Int. application no. | SG2009000473 | | Int. publication no. | WO2010068181 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
